Cambridge Equities, LP

Holdings History for ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)

Symbol: IBRX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 745,576,456 shares
Security Ownership %: 66%

Patrick Soon-Shiong ownership in ImmunityBio, Inc. Common Stock, par value $0.0001 per share (IBRX)

25 Feb 2026 - Patrick Soon-Shiong has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 745,576,456 shares of ImmunityBio, Inc. Common Stock, par value $0.0001 per share (IBRX). This represents 66% ownership of the company. In their previous filing dated 10 Nov 2025, Cambridge Equities, LP had reported owning 743,971,200 shares, indicating an increase of +0.22%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Patrick Soon-Shiong	66%	-3.8%	$4,406,356,855	745,576,456	+1,605,256	+0.22%	$5.91	13D/A	23 Feb 2026	25 Feb 2026, 21:51
Patrick Soon-Shiong	69%		$1,830,169,152	743,971,200			$2.46	13D/A	10 Nov 2025	10 Nov 2025, 19:43